Your latest news:
Interests in hearing insights on the pharmaceutical packaging supply chain? Access our on demand webinars here and sign up to access our next one!
Your latest news:
Interests in hearing insights on the pharmaceutical packaging supply chain? Access our on demand webinars here and sign up to access our next one!
Novartis has abandoned its undisclosed, high-risk, high-reward obesity candidate after disappointing results in a phase 2 trial. The Swiss pharmaceutical
In order to prevent shortages of antibiotics, the European Health Union is taking proactive measures. The European Commission, in collaboration
Lonza and Vertex Pharmaceuticals have joined forces to support the production of innovative cell therapies for Type 1 diabetes. This
The global pursuit of sustainability is becoming increasingly impossible to overlook. It now plays a prominent role in shaping various
Novartis, the Swiss pharmaceutical company, announced its intention to acquire Chinook Therapeutics, a biotech firm based in the United States,
Pfizer Inc (PFE.N) has decided to discontinue the development of its once-a-day experimental obesity pill due to concerns regarding liver
Vaxxas, a biotech company specializing in vaccination technology, has opened a state-of-the-art manufacturing facility in Brisbane, Queensland. The 5,500 square
A select assortment of Bristol Myers Squibb’s medicines are headed into orbit where researchers will study the crystallization of the biotherapeutics in microgravity.
A two-chamber setup (TCS) for containment investigations could predict the dustiness of HPAPIs in a sealed system at different flow
Luye Pharma, the international pharmaceutical company, has developed a drug called Rykindo which has been approved by the FDA. This
Pharmaceutical Technology analyses recent trial and regulatory-related announcements that will likely impact therapy manufacturing plans. In this last 2022 edition
Explore Drug Solutions Podcast lates podcast as it looks back at the challenges and innovation highlights in 2022 for oral solid dosage forms, reviewing industry experts’ takes on factors driving the evolution of OSD forms and much more.
